207 related articles for article (PubMed ID: 11304695)
21. Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743.
Soares DG; Escargueil AE; Poindessous V; Sarasin A; de Gramont A; Bonatto D; Henriques JA; Larsen AK
Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13062-7. PubMed ID: 17656556
[TBL] [Abstract][Full Text] [Related]
22. Analysis of DNA repair-related genes in breast cancer reveals CUL4A ubiquitin ligase as a novel biomarker of trabectedin response.
García MJ; Saucedo-Cuevas LP; Muñoz-Repeto I; Fernández V; Robles MJ; Domingo S; Palacios J; Aracil M; Nieto A; Tercero JC; Benítez J
Mol Cancer Ther; 2013 Apr; 12(4):530-41. PubMed ID: 23364677
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair.
Takebayashi Y; Pourquier P; Zimonjic DB; Nakayama K; Emmert S; Ueda T; Urasaki Y; Kanzaki A; Akiyama SI; Popescu N; Kraemer KH; Pommier Y
Nat Med; 2001 Aug; 7(8):961-6. PubMed ID: 11479630
[TBL] [Abstract][Full Text] [Related]
24. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
[TBL] [Abstract][Full Text] [Related]
25. In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction.
Brandon EF; Meijerman I; Klijn JS; den Arend D; Sparidans RW; Lázaro LL; Beijnen JH; Schellens JH
Anticancer Drugs; 2005 Oct; 16(9):935-43. PubMed ID: 16162970
[TBL] [Abstract][Full Text] [Related]
26. Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA.
Bonfanti M; La Valle E; Fernandez Sousa Faro JM; Faircloth G; Caretti G; Mantovani R; D'Incalci M
Anticancer Drug Des; 1999 Jun; 14(3):179-86. PubMed ID: 10500494
[TBL] [Abstract][Full Text] [Related]
27. DNA-PK: the major target for wortmannin-mediated radiosensitization by the inhibition of DSB repair via NHEJ pathway.
Hashimoto M; Rao S; Tokuno O; Yamamoto K; Takata M; Takeda S; Utsumi H
J Radiat Res; 2003 Jun; 44(2):151-9. PubMed ID: 13678345
[TBL] [Abstract][Full Text] [Related]
28. Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks.
Chernikova SB; Wells RL; Elkind MM
Radiat Res; 1999 Feb; 151(2):159-66. PubMed ID: 9952300
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of enhancement of cytotoxicity in etoposide and ionising radiation-treated cells by the protein kinase inhibitor wortmannin.
Boulton S; Kyle S; Durkacz BW
Eur J Cancer; 2000 Mar; 36(4):535-41. PubMed ID: 10717533
[TBL] [Abstract][Full Text] [Related]
30. Unique features of trabectedin mechanism of action.
Larsen AK; Galmarini CM; D'Incalci M
Cancer Chemother Pharmacol; 2016 Apr; 77(4):663-71. PubMed ID: 26666647
[TBL] [Abstract][Full Text] [Related]
31. Dual inhibition of ATR and ATM potentiates the activity of trabectedin and lurbinectedin by perturbing the DNA damage response and homologous recombination repair.
Lima M; Bouzid H; Soares DG; Selle F; Morel C; Galmarini CM; Henriques JA; Larsen AK; Escargueil AE
Oncotarget; 2016 May; 7(18):25885-901. PubMed ID: 27029031
[TBL] [Abstract][Full Text] [Related]
32. Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives.
Vincenzi B; Napolitano A; Frezza AM; Schiavon G; Santini D; Tonini G
Pharmacogenomics; 2010 Jun; 11(6):865-78. PubMed ID: 20504257
[TBL] [Abstract][Full Text] [Related]
33. Low cytotoxicity of ecteinascidin 743 in yeast lacking the major endonucleolytic enzymes of base and nucleotide excision repair pathways.
Soares DG; Poletto NP; Bonatto D; Salvador M; Schwartsmann G; Henriques JA
Biochem Pharmacol; 2005 Jul; 70(1):59-69. PubMed ID: 15913564
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
Uboldi S; Bernasconi S; Romano M; Marchini S; Fuso Nerini I; Damia G; Ganzinelli M; Marangon E; Sala F; Clivio L; Chiorino G; Di Giandomenico S; Rocchi M; Capozzi O; Margison GP; Watson AJ; Caccuri AM; Pastore A; Fossati A; Mantovani R; Grosso F; Tercero JC; Erba E; D'Incalci M
Int J Cancer; 2012 Jul; 131(1):59-69. PubMed ID: 21805478
[TBL] [Abstract][Full Text] [Related]
35. ET-743.
Cvetkovic RS; Figgitt DP; Plosker GL
Drugs; 2002; 62(8):1185-92; discussion 1193-4. PubMed ID: 12010079
[TBL] [Abstract][Full Text] [Related]
36. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes.
Shao RG; Cao CX; Zhang H; Kohn KW; Wold MS; Pommier Y
EMBO J; 1999 Mar; 18(5):1397-406. PubMed ID: 10064605
[TBL] [Abstract][Full Text] [Related]
37. Marked activity of irofulven toward human carcinoma cells: comparison with cisplatin and ecteinascidin.
Poindessous V; Koeppel F; Raymond E; Comisso M; Waters SJ; Larsen AK
Clin Cancer Res; 2003 Jul; 9(7):2817-25. PubMed ID: 12855662
[TBL] [Abstract][Full Text] [Related]
38. Wortmannin inhibits repair of DNA double-strand breaks in irradiated normal human cells.
Okayasu R; Suetomi K; Ullrich RL
Radiat Res; 1998 May; 149(5):440-5. PubMed ID: 9588354
[TBL] [Abstract][Full Text] [Related]
39. Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage.
Boulton S; Kyle S; Durkacz BW
Carcinogenesis; 1999 Feb; 20(2):199-203. PubMed ID: 10069454
[TBL] [Abstract][Full Text] [Related]
40. Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin.
Herrero AB; Martín-Castellanos C; Marco E; Gago F; Moreno S
Cancer Res; 2006 Aug; 66(16):8155-62. PubMed ID: 16912194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]